Have a feature idea you'd love to see implemented?
Let us know!
ALLR Allarity Therapeutics Inc
Price (delayed)
$1.26
Market cap
$5.59M
P/E Ratio
0
Dividend/share
N/A
EPS
$4,796.84
Enterprise value
-$11.54M
Highlights
Allarity Therapeutics's EPS has surged by 101% YoY and by 39% QoQ
Allarity Therapeutics's quick ratio has increased by 38% QoQ
Allarity Therapeutics's net income has shrunk by 61% QoQ and by 44% YoY
ALLR's equity is down by 35% from the previous quarter
Key stats
What are the main financial stats of ALLR
Market
Valuations
Earnings
Shares outstanding
4.43M
Market cap
$5.59M
Enterprise value
-$11.54M
Price to earnings (P/E)
0
Price to book (P/B)
0.14
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$18.27M
EBITDA
-$18.26M
Free cash flow
-$15.82M
Per share
Balance sheet
Liquidity
EPS
$4,796.84
Free cash flow per share
-$10.04
Book value per share
$9.18
Revenue per share
$0
TBVPS
$12.93
Total assets
$20.38M
Total liabilities
$7.41M
Debt
$1.34M
Equity
$12.96M
Working capital
$12.95M
Debt to equity
0.1
Current ratio
2.75
Quick ratio
2.49
Net debt/EBITDA
0.94
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-103.5%
Return on equity
-329.5%
Return on invested capital
N/A
Return on capital employed
-141%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALLR stock price
How has the Allarity Therapeutics stock price performed over time
Intraday
5.88%
1 week
-10.64%
1 month
-22.7%
1 year
-99.59%
YTD
-99.62%
QTD
-40.28%
Financial performance
How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.8M
Net income
-$18.78M
Gross margin
N/A
Net margin
N/A
Allarity Therapeutics's net income has shrunk by 61% QoQ and by 44% YoY
ALLR's operating income is down by 47% since the previous quarter and by 31% year-on-year
Growth
What is Allarity Therapeutics's growth rate over time
Valuation
What is Allarity Therapeutics stock price valuation
P/E
0
P/B
0.14
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Allarity Therapeutics's EPS has surged by 101% YoY and by 39% QoQ
ALLR's equity is down by 35% from the previous quarter
Efficiency
How efficient is Allarity Therapeutics business performance
ALLR's ROE has soared by 54% QoQ
Allarity Therapeutics's ROA has decreased by 38% from the previous quarter but it has increased by 35% YoY
Dividends
What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALLR.
Financial health
How did Allarity Therapeutics financials performed over time
ALLR's total assets is 175% more than its total liabilities
Allarity Therapeutics's total liabilities has plunged by 57% YoY and by 33% from the previous quarter
ALLR's total assets is up by 47% YoY but it is down by 34% from the previous quarter
The company's debt is 90% lower than its equity
ALLR's debt to equity has surged by 129% year-on-year and by 43% since the previous quarter
ALLR's equity is down by 35% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.